NCT03799614

Vibration Impact on Parkinson's Tremor

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 30 (actual)
• Sponsor: Virginia Commonwealth University · Academic / Other
• Sex: All
• Age: 21 Years – 95 Years
• Healthy volunteers: Not accepted

Summary

The primary purpose of this study is to test the safety, tolerability and efficacy of vibration (delivered by an experimental device called RMBand that is worn on the subject's arm) on parkinsonian tremor. The RMBand was developed by Resonate Forward, LLC (RF). This RMBand is designed to administer a vibration to the wearer to decrease or stop tremor in persons with Parkinson's disease (PD).

Detailed description

Participation will be completed in one visit at VCU Parkinson's and Movement Disorders Center. A baseline Movement Disorder Society Unified Parkinson Disease Rating Scale (MDS-UPDRS) will be taken prior to vibration therapy. The RMBand (experimental device) will be placed on the arm of the participant to provide the vibration therapy. The MDS-UPDRS Part III will be repeated both during and after the therapy. Participants will be asked to provide feedback about the device, the therapy session and how they are feeling.

Conditions

• Parkinson Disease

Interventions

Type	Name	Description
DEVICE	RMBand lower dose	Light-weight portable device that delivers low dose vibration to the arm
DEVICE	RMBand higher dose	Light-weight portable device that delivers higher dose vibration to the arm

Timeline

• Start date: 2019-02-26
• Primary completion: 2019-11-27
• Completion: 2019-11-27
• First posted: 2019-01-10
• Last updated: 2020-12-17
• Results posted: 2020-12-17

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study